Exact Mass: 649.2275434

Exact Mass Matches: 649.2275434

Found 44 metabolites which its exact mass value is equals to given mass value 649.2275434, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

2-(4-(Bis(carboxymethyl)amino)-3-(2-(2-(bis(carboxymethyl)amino)-5-methylphenoxy)ethoxy)phenyl)-1H-indole-6-carboxylic acid

2-(4-(Bis(carboxymethyl)amino)-3-(2-(2-(bis(carboxymethyl)amino)-5-methylphenoxy)ethoxy)phenyl)-1H-indole-6-carboxylic acid

C32H31N3O12 (649.1907646)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D064449 - Sequestering Agents > D002614 - Chelating Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

Malvidin 3-caffeoyl-glucoside

3-{[(2S,3R,4S,5S,6R)-6-({[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-(3-ethenyl-5-methoxy-4-methylphenyl)-5,7-dihydroxy-1λ⁴-chromen-1-ylium

C34H33O13 (649.1921068)


Malvidin 3-caffeoyl-glucoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Malvidin 3-caffeoyl-glucoside can be found in common grape, which makes malvidin 3-caffeoyl-glucoside a potential biomarker for the consumption of this food product.

   

Dihydro,di-Ac-Ravidomycin

Dihydro,di-Ac-Ravidomycin

C35H39NO11 (649.2522984)


   
   

Met Gln Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C32H39N7O6S (649.2682394000001)


   

Met Trp Gln Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C32H39N7O6S (649.2682394000001)


   

Met Trp Trp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C32H39N7O6S (649.2682394000001)


   

Gln Met Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C32H39N7O6S (649.2682394000001)


   

Gln Trp Met Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

C32H39N7O6S (649.2682394000001)


   

Gln Trp Trp Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C32H39N7O6S (649.2682394000001)


   

Raloxifene 6-glucuronide

Raloxifene-6-glucuronide

C34H35NO10S (649.198157)


   

Raloxifene-4-glucuronide

Raloxifene-4-glucuronide

C34H35NO10S (649.198157)


   

Trp Met Gln Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C32H39N7O6S (649.2682394000001)


   

Trp Met Trp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C32H39N7O6S (649.2682394000001)


   

Trp Gln Met Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

C32H39N7O6S (649.2682394000001)


   

Trp Gln Trp Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C32H39N7O6S (649.2682394000001)


   

Trp Trp Met Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C32H39N7O6S (649.2682394000001)


   

Trp Trp Gln Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoic acid

C32H39N7O6S (649.2682394000001)


   

TCYTY

Thr Cys Tyr Thr Tyr

C29H39N5O10S (649.2417514)


   

Nintedanib Esylate

Nintedanib Ethanesulfonate Salt

C33H39N5O7S (649.2570064)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents

   

UNII:73033I28Y6

Mosapride citrate dihydrate

C27H37ClFN3O12 (649.2049684000001)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents

   

N4-benzoyl-3,5-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-2-O-[(methylthio)methyl]cytidine

N4-benzoyl-3,5-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-2-O-[(methylthio)methyl]cytidine

C30H47N3O7SSi2 (649.2673112)


   
   

5-DMT-Bz-rC

5-DMT-Bz-rC

C37H35N3O8 (649.2424030000001)


5'-O-DMT-Bz-Rc is a modified nucleoside and can be used to synthesize DNA or RNA.

   

bis(trimethylsilyl)azanide,thulium(3+)

bis(trimethylsilyl)azanide,thulium(3+)

C18H54N3Si6Tm (649.2275434)


   

Sibofimloc

Antibiotic-202

C35H39NO11 (649.2522984)


C254 - Anti-Infective Agent > C258 - Antibiotic

   

Glycine, N-[2-[[(9H-fluoren-9-ylMethoxy)carbonyl]aMino]ethyl]-N-[[6-[[(phenylMethoxy)carbonyl]aMino]-9H-purin-9-yl]acetyl]-

Glycine, N-[2-[[(9H-fluoren-9-ylMethoxy)carbonyl]aMino]ethyl]-N-[[6-[[(phenylMethoxy)carbonyl]aMino]-9H-purin-9-yl]acetyl]-

C34H31N7O7 (649.2284855999999)


   

PF 3084014 hydrobromide

PF 3084014 hydrobromide

C27H43Br2F2N5O (649.1802211999999)


C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

Malvidin 3-caffeoyl-glucoside

Malvidin 3-caffeoyl-glucoside

C34H33O13+ (649.1921068)


   
   

alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp

alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp

C23H39NO20 (649.2065334)


alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp in which the anomeric configuration of the reducing-end glucose is beta.

   
   

alpha-Neu5Gc-(2->6)-beta-Gal-(1->4)-Glc

alpha-Neu5Gc-(2->6)-beta-Gal-(1->4)-Glc

C23H39NO20 (649.2065334)


   

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide

C32H38F3N3O6S (649.2433284000001)


   

NeuGc(a2-3)[Gal(b1-4)]Gal

NeuGc(a2-3)[Gal(b1-4)]Gal

C23H39NO20 (649.2065334)


   

3,5-dideoxy-5-glycolamido-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose

3,5-dideoxy-5-glycolamido-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose

C23H39NO20 (649.2065334)


   

NeuGc(a2-6)Gal(b1-4)b-Glc

NeuGc(a2-6)Gal(b1-4)b-Glc

C23H39NO20 (649.2065334)


   

NeuGc(a2-3)[Gal(b1-4)]a-Gal

NeuGc(a2-3)[Gal(b1-4)]a-Gal

C23H39NO20 (649.2065334)


   

NeuGc(a2-3)[Gal(b1-4)]b-Gal

NeuGc(a2-3)[Gal(b1-4)]b-Gal

C23H39NO20 (649.2065334)


   

Indo 1

2-(4-(Bis(carboxymethyl)amino)-3-(2-(2-(bis(carboxymethyl)amino)-5-methylphenoxy)ethoxy)phenyl)-1H-indole-6-carboxylic acid

C32H31N3O12 (649.1907646)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D064449 - Sequestering Agents > D002614 - Chelating Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp

alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp

C23H39NO20 (649.2065334)


An amino trisaccharide consisting of an N-glycoloylneuraminosyl residue linked alpha(2->3) to a lactose moiety.

   
   

FASN-IN-4 (tosylate)

FASN-IN-4 (tosylate)

C33H35N3O7S2 (649.191632)


FASN-IN-4 tosylate is a potent inhibitor of fatty acid synthase (FASN) with an IC50 of 10 nM (WO2012064642A1, compound 29)[1]. FASN-IN-4 tosylate also inhibits SARS-CoV-2 with an EC50 of 18.6?nM[2].